0001213900-24-012255.txt : 20240313 0001213900-24-012255.hdr.sgml : 20240313 20240212070021 ACCESSION NUMBER: 0001213900-24-012255 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PolyPid Ltd. CENTRAL INDEX KEY: 0001611842 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 18 HASIVIM STREET CITY: PETACH TIKVA STATE: L3 ZIP: 495376 BUSINESS PHONE: 972-74-7195700 MAIL ADDRESS: STREET 1: 18 HASIVIM STREET CITY: PETACH TIKVA STATE: L3 ZIP: 495376 CORRESP 1 filename1.htm

PolyPid Ltd.

18 Hasivim Street

Petach Tikva

495376, Israel

February 12, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

	RE:	PolyPid Ltd. (CIK 0001611842)
		Registration Statement No. 333-276826 on Form F-3 (the “Registration Statement”)

Ladies and Gentlemen:

PolyPid Ltd. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on February 13, 2024, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.

The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

	Very truly yours,

	POLYPID LTD.

	By:	/s/ Dikla Czaczkes Akselbrad
		Dikla Czaczkes Akselbrad Chief Executive Officer